 |
Other Abstracts
Loiler, S., Song, S., Warrington, K.H., Agarwal A., Kapturczak,
M., Li, C., Ricordi, C., Atkinson, M.A., Muzyczka,N., Flotte,
T.R. (2002) Enhanced transduction of pancreatic islet cells
with targeted recombinant adeno-associated virus vectors.
Molecular Therapy, 5(5, part2 of part2):S429.
Goudy, K., Wasserfall, Clive., Burkhardt, B., Brusko, T.,
Song, S., Ellis, T., Flotte, T.R., Atkinson, M.A. (2002) Elucidation
of time and dose dependencies using AAV-IL-10 gene therapy
for prevetion of type 1 diabetes in the NOD mouse. Molecular
Therapy, 5(5, part2 of part2):S17.
Goudy, K., Wasserfall, C., Burkhardt, B., Brusko, T., Song,
S., Ellis, T., Flotte, T., Atkinson, M. Evaluation of Mechanism,
Dose, and Time Dependency for AAV-IL-10 Gene Therapy in NOD
Mice. Abstract for 2002 American Diabetes Association Annual
Meeting.
Song, S., Goudy, K., Wasserfall, C., Wang, J., Ottendorfer,
E., Ellis, T., Crawford, J. M., Atkinson, M. Flotte, T. R.
Adeno-Associated Virus (AAV2) Vector Mediated IL-10 Gene Delivery
Prevents Type I Diabetes in NOD Mice. Molecular Therapy, 3(5)
S306, 2001.
Loiler, S.A., Wang, J., Song, S., Atkinson, M, Flotte, T.R.,
Optimizing Promoter Expression and Transduction Efficiency
of Human Islet Cells for the Treatment of Type I Diabetes.
Molecular Therapy, 3(5) S179, 2001.
|
